Study of Galunisertib in Healthy Participants
Clinical trial NCT02752919 · COMPLETED
Trial details
- NCT number
- NCT02752919
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.